Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma
Clinical trial NCT02619253 · COMPLETED
Trial details
- NCT number
- NCT02619253
- Sponsor
- Nabil Adra
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2023-03-28
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.